Get Signals
Stay ahead with weekly email digests of Italian funds activity. With agentic coding PE/VC databases have no reason to cost €X000/month.
Cancel anytime
- ✓New deals and investments
- ✓Portfolio exits and IPOs
- ✓Fund launches and fundraises
- ✓Key hires and leadership changes
- ✓Weekly digest delivered to your inbox
- ✓Request custom features
Payments processed securely by Stripe. You can cancel your subscription at any time.
By subscribing, you agree to our Terms, Privacy Policy and Cookie Policy.
Sample signals from our feed
Star Capital sgr has launched its fifth fund, Star V Private Equity, following an initial closing of €60M. Fundraising began in June 2024, and the final target is 200 million
Neopharmed Gentili, an Italian pharmaceutical company controlled by Ardian and Renaissance Partners along with the Del Bono family, has issued a new €425M senior secured floating-rate bond maturing in 2033 to refinance
Origine-SGR led X-nano’s €3.7M seed round to fund a pilot plant for sustainable synthetic graphite
What subscribers say
“I use Fundradar to stay on top of the industry and track what competitors are doing without relying on what newspapers choose to publish.”
“Fundradar allows me to anticipate where my support will be most needed, so I can prepare focused materials and deepen my knowledge accordingly.”
“Fundradar helps me track where the market is moving and prepare experienced candidate profiles before clients ask for them.”